Wealthfront’s Mead Johnson Nutrition Company MJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,921
Closed -$260K 481
2017
Q1
$260K Buy
+2,921
New +$240K ﹤0.01% 365
2015
Q4
Sell
-935
Closed -$66K 1285
2015
Q3
$66K Sell
935
-714
-43% -$58.7K ﹤0.01% 481
2015
Q2
$149K Sell
1,649
-1,100
-40% -$106K 0.01% 320
2015
Q1
$276K Buy
2,749
+240
+10% +$24.2K 0.01% 179
2014
Q4
$252K Buy
2,509
+577
+30% +$57.5K 0.01% 158
2014
Q3
$186K Buy
1,932
+735
+61% +$69.6K 0.01% 167
2014
Q2
$112K Buy
1,197
+675
+129% +$59K 0.01% 201
2014
Q1
$45K Buy
+522
New +$42.3K 0.01% 290

Other funds holding MJN

Wealthfront's MJN Position: Q2 2017 in Review

Wealthfront sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 2,921 shares — an estimated $260K sold.

Wealthfront first reported a position in MJN in Q1 2014 and held it in 8 quarters. The position peaked at $276K in Q1 2015. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Wealthfront reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Wealthfront sold 2,921 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $260K.
  • Wealthfront first reported a position in Mead Johnson Nutrition Company in Q1 2014 and held it in 8 quarters.
  • Wealthfront's Mead Johnson Nutrition Company position peaked at $276K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Wealthfront's 13F filing for Q2 2017, filed 11 Aug 2017.